Keywords 1,2,3-Triazole 1,4-Dihydropyridine Hybrids Water mediated Anti-bacterial Anti-inﬂammatory Introduction 1,4-Dihydropyridines (1,4-DHPs) have been used for the treatment of cardiovas- cular disease  and hypertension [2, 3]. They also show a broad range of pharmacological action in bronchodilaton, vasodilation, hepatoprotection, geropro- tection and exhibit bioactivities such as in the antitumor, antimutagenic, antiatherosclerotic, antidiabetic activities [4, 5]. Some commercially available drugs, which contain 1,4-DHP core are Nifedipine, Amlodipine, Lacidipine, Isradipine, Nimodipine, Nisoldipine, and lercenadipine (Fig. 1). On the other hand, 1,2,3-triazoles show bioactivities such as antibacterial, herbicidal, fungicidal, and anti-HIV activities [6–9]. Recent studies are being oriented towards the synthesis of hybrid bioactive compounds, the molecular frameworks of which are made up of two or more heterocyclic scaffolds. It has been reported that the combination of two heterocyclic skeletons having different biological functions produce new hybrid compounds that are more medically effective than their parent molecules . In this regard, we have reported commendable bioactivities of 1,2,3-triazolyl-2-aminopyrimidine hybrids and 1,2,3-triazolyl dihydropyrimidine-2-thione hybrids [11, 12]. A similar report by Kumbhare et al.  deals with the synthesis of a dihydropyridine-1,2,3-triazole hybrids and their ACE inhibitory activity. This report discloses that the 1,2,3-triazole moiety has a pronounced effect in
Research on Chemical Intermediates – Springer Journals
Published: Jun 24, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud